I stopped just 'chatting' with AI and started shipping. I vibe-coded a functional app in 48 hours—here is the exact, no-code ...
Vibe coding apps ship with alarming security flaws. What founders need to know about AI-generated code vulnerabilities in ...
With Gemini and a simple Python script, I rebuilt YouTube email alerts. Now I won't miss another comment. Here's how you can do the same.
The consensus among early adopters is that Anthropic has successfully internalized the most desirable features of the open-source movement—multi-channel support and long-term memory ...
STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, has announced a new generation of entry-level microcontrollers (MCUs) ...
The Seattle Opera fired off a tongue-in-cheek rebuttal in response to Timothée Chalamet’s comments about the ballet and opera on Saturday. The company announced a discount code—the actor’s first ...
Within three years, no embedded software developer is going to be writing code. I know it sounds like another one of my controversial statements. But I recently used Claude Code to write the best ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
We all use LLMs daily. Most of us use them at work. Many of us use them heavily. People in tech — yes, you — use LLMs at twice the rate of the general population. Many of us spend more than a full day ...
Code Metal, a Boston-based startup that uses AI to write code and translate it into other programming languages, just closed a $125 million Series B funding round from new and existing investors. The ...
During the company’s Q4 earnings call, Gustav Söderström revealed that Spotify had fully embraced vibe coding. AI is coming for a lot of jobs, and software developer is high on the list of those in ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...